UBS Group »

Kiniksa Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 85k 17.53
2023-09-30 $1.1M 63k 17.00
2023-06-30 $628k 45k 14.08
2023-03-31 $552k 51k 10.75
2022-12-31 $856k 57k 14.98
2022-03-31 $12k 1.2k 10.23
2021-12-31 $901k 77k 11.77
2021-09-30 $942k 83k 11.39
2021-06-30 $279k 20k 13.94
2021-03-31 $660k 36k 18.52
2020-12-31 $24k 1.4k 17.56
2020-09-30 $38k 2.5k 15.14
2020-06-30 $271k 11k 25.44
2020-03-31 $112k 7.2k 15.53
2019-12-31 $210k 19k 11.07
2019-09-30 $80k 9.4k 8.54
2019-06-30 $23k 1.7k 13.26
2018-09-30 $39k 1.5k 25.49